»ó´Ü¿©¹é
±â»ç (Àüü 111°Ç)
[Interview] ¡°Å׳׸®±Û¸³Æ¾, ÀÓ»óÇöÀå¿¡¼­ ü°¨ÇÒ ¼ö ÀÖ´Â °­·ÂÇÑ DPP-4¾ïÁ¦Á¦¡± ÀÓ¼¼Çü ±âÀÚ 2023-11-07 17:48
[Interview] Áß°­µµ ½ºÅ¸Æ¾+¿¡Á¦Æ¼¹Ìºê,
°í°­µµ ½ºÅ¸Æ¾ ´ëºñ
CVD ¿¹¹æ¡¤NODM¡¤¾à¹°Áß´Ü ¸é¿¡¼­ À̵æ ÈξÀ Ä¿
THE MOST 2023-10-04 17:09
[Interview] ±¹³» ÃÖÃÊÀÇ 4Á¦ º¹ÇÕÁ¦ ¾Æ¸ðÀßź¿¢½ºÅ¥
±¹³» ȯÀÚ´ë»ó 3»ó¿¬±¸ °á°ú ±¹Á¦ÇмúÁö °ÔÀç
ÀÌ»óµ· ±âÀÚ 2023-10-04 16:51
[Interview] ¡°Ä¿ÇÁ¾ø´Â Ç÷¾ÐÃøÁ¤±â ¿¬¼ÓÇ÷¾ÐÃøÁ¤ ÆíÀǼº °³¼±¿¡ µµ¿ò¡± ÀÓ¼¼Çü ±âÀÚ 2023-10-04 16:20
[Interview] ¡°À§Àå°ü°è ºÎÀÛ¿ë ÁÙÀÎ ÆÐÃëÁ¦·Î
µµ³×ÆäÁú Ä¡·áÈ¿°ú À¯Áö¡±
ÀÓ¼¼Çü ±âÀÚ 2023-09-06 11:10
¶óÀÎ
[Interview] ¡°GERD¿¡ P-CAB ÃÊÄ¡·á °¡´É¼º¡è¡± ÀÌ»óµ· ±âÀÚ 2023-08-07 16:15
[Interview] ¡°Áö¼ÓÀû BÇü°£¿° Ä¡·á¸¦ À§ÇÑ ¿É¼Ç¡± ÀÓ¼¼Çü ±âÀÚ 2023-08-07 10:04
[Interview] ³úÁ¹Áß¡¤½É¹æ¼¼µ¿ µ¿¹Ý½Ã ±Þ¼º±â °æ±¸Ç×ÀÀ°íÄ¡·á¿¡ NOAC ÇýÅáè ÀÌ»óµ· ±âÀÚ 2023-07-05 16:26
[Interview] ¡°¿þ¾î·¯ºí ½ÉÀüµµ ±â±â, ½É¹æ¼¼µ¿ ¼±º°°Ë»ç ´ë¾ÈÀ¸·Î ±â´ë¡± ÀÓ¼¼Çü ±âÀÚ 2023-07-05 16:22
[Interview] Çѱ¹ÀÎ ACS ȯÀÚ, ¸ÂÃãÇü DAPT Àü·« ÇÊ¿äÇÏ´Ù ÀÓ¼¼Çü ±âÀÚ 2023-07-05 14:54
¶óÀÎ
[Interview] Æø³ÐÀº 2Çü´ç´¢º´ ȯÀÚ¿¡¼­ ÇýÅà ±â´ë ÀÓ¼¼Çü ±âÀÚ 2023-06-05 14:51
[Interview] ¡°SGLT-2i/TZD, ´Ù¸¥ ±âÀüÀÇ Á¶ÇÕÀ¸·Î ½Ã³ÊÁö È¿°ú ±â´ë¡± ÀÓ¼¼Çü ±âÀÚ 2023-06-05 14:18
[Interview] ´ç´¢º´ ȯÀÚÀÇ ³úÁ¹Áß °ü¸® À§ÇÑ È¿À²Àû ¹æ¾È ÀÓ¼¼Çü ±âÀÚ 2023-06-05 13:16
[Interview] ¡°´ÙȸÀν¶¸°ÁÖ»ç¿ä¹ý ȯÀÚ, °ü¸® ½Ã½ºÅÛ ºÎÀçÇÏ´Ù¡± ÀÓ¼¼Çü ±âÀÚ 2023-06-05 12:59
[Interview] ¡°½ºÅ¸Æ¾ ´Üµ¶¿ä¹ý ÀÌ»óÁöÁúÇ÷Áõ °ü¸®ÀÇ ½ÃÀÛ¡± ÀÓ¼¼Çü ±âÀÚ 2023-05-04 16:45
¶óÀÎ
[Interview] ¡°ÀþÀº ¼ºÀκÎÅÍ Àû±ØÀûÀ¸·Î LDL-C °ü¸®Çؾߡ± ÀÓ¼¼Çü ±âÀÚ 2023-05-04 16:24
[Interview] LDL-C Ä¡·á Æз¯´ÙÀÓ, The Lower¡¤The Earlier ÀÌ»óµ· ±âÀÚ 2023-05-04 14:32
[Interview] À̳ªº¸±Û¸®Ç÷ÎÁø ¿¬±¸³í¹® ¸®ºä¾îµé
¡°¼¼°è ´ç´¢º´ Ä¡·á À§ÇÑ ¾àÁ¦¡¤±Ù°Å¿¡ °¨»ç¡±
ÀÌ»óµ· ±âÀÚ 2023-05-04 11:05
[Interview] ¡°¿ì¼öÇÑ È¿°ú¿Í ¾ÈÀü¼ºÀ¸·Î ½Ã³ÊÁö ±â´ëÇÒ ¼ö ÀÖ´Â À§¿° Ä¡·áÁ¦¡± ÀÓ¼¼Çü ±âÀÚ 2023-05-04 10:58
[Interview] ¡°±¹³» COPD Áø·áÁöħ°ú ¹æÇ⠸¾Ҵ١± ÀÓ¼¼Çü ±âÀÚ 2023-04-03 18:12
Back to Top